UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 25

of '胰高血糖素瘤和胰高血糖素瘤综合征'

25
TI
Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
AU
Rosenbaum A, Flourie B, Chagnon S, Blery M, Modigliani R
SO
Digestion. 1989;42(2):116.
 
We report 1 patient with a necrolytic migratory erythema, a high plasma glucagon concentration and a metastatic pancreatic endocrine tumor who has now been treated effectively for 33 months with the somatostatin analogue octreotide (SMS 201-995) (400 micrograms/day). The results of SMS 201-995 in the treatment of glucagonoma syndrome are reviewed.
AD
Service de Gastroentérologie, Hôpital Saint-Lazare, Paris, France.
PMID